Lite Strategy

Lite Strategy is a clinical-stage pharmaceutical company listed on NASDAQ (LITS), specializing in innovative drug development for oncology and autoimmune disorders. Established in 2018, the company leverages blockchain technology to enhance data security, streamline supply chain transparency, and ensure regulatory compliance in clinical trials. Its proprietary platform integrates smart contracts for efficient trial management and real-time tracking of pharmaceutical assets. With a pipeline of 12